Tetherin restricts HSV-2 release and is counteracted by multiple viral glycoproteins

被引:25
|
作者
Liu, Yalan [1 ]
Luo, Sukun [1 ,2 ]
He, Siyi [1 ,2 ]
Zhang, Mudan [1 ,2 ]
Wang, Ping [1 ,2 ]
Li, Chang [1 ,2 ]
Huang, Wenjie [1 ]
Hu, Bodan [1 ,2 ]
Griffin, George E. [3 ]
Shattock, Robin J. [4 ]
Hu, Qinxue [1 ,3 ]
机构
[1] Chinese Acad Sci, State Key Lab Virol, Wuhan Inst Virol, Wuhan 430071, Peoples R China
[2] Univ Chinese Acad Sci, Beijing 100049, Peoples R China
[3] St Georges Univ London, Inst Infect & Immun, London SW17 0RE, England
[4] Univ London Imperial Coll Sci Technol & Med, Infect Dis Sect, Fac Med, London W2 1PG, England
基金
中国国家自然科学基金;
关键词
HSV-2; Tetherin; Viral release; Viral glycoprotein; HERPES-SIMPLEX-VIRUS; DOWN-REGULATION; HIV-1; RELEASE; CELL-SURFACE; PROTEIN; EXPRESSION; INFECTION; VPU; COMPLEX; TYPE-1;
D O I
10.1016/j.virol.2014.11.005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Tetherin has been defined as a restriction factor of HIV-1 and several other enveloped viruses. However, the significance of tetherin in viral infection remains to be further addressed. Here, we investigated whether tetherin plays a role in HSV-2 infection. Our study revealed that overexpression of tetherin restricted the release of HSV-2 into the extracellular medium, while knockdown of tetherin by siRNA enhanced its release. We further demonstrated that HSV-2 infection and viral glycoproteins gB, gD, gH and gL but not gM significantly downregulated the endogenous expression of tetherin. Additional study indicated that tetherin likely physically interacted with gB, gD, gH and gL. This is the first time that tetherin has been shown to be counteracted by multiple viral components of a virus. Our findings inform the complexity of HSV-2-host interactions, providing basis for understanding the role of tetherin as a viral restriction factor and the mechanisms underlying viral countermeasures. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:96 / 109
页数:14
相关论文
共 50 条
  • [31] Intravaginal immunization with viral subunit protein plus CpG oligodeoxynucleotides induces protective immunity against HSV-2
    Kwant, A
    Rosenthal, KL
    VACCINE, 2004, 22 (23-24) : 3098 - 3104
  • [32] MOLECULAR-CLONING OF HSV-2 AND ANALYSIS OF CROSS-HYBRIDIZATION BETWEEN THE VIRAL AND DIFFERENT CELLULAR GENOMES
    KOHLER, E
    SANDER, U
    MUNK, K
    BRAUN, R
    ZENTRALBLATT FUR BAKTERIOLOGIE MIKROBIOLOGIE UND HYGIENE SERIES A-MEDICAL MICROBIOLOGY INFECTIOUS DISEASES VIROLOGY PARASITOLOGY, 1987, 264 (1-2): : 263 - 263
  • [33] Contribution of N-linked glycans on HSV-2 gB to cell-cell fusion and viral entry
    Luo, Sukun
    Hu, Kai
    He, Siyi
    Wang, Ping
    Zhang, Mudan
    Huang, Xin
    Du, Tao
    Zheng, Chunfu
    Liu, Yalan
    Hu, Qinxue
    VIROLOGY, 2015, 483 : 72 - 82
  • [34] Characterization of Inherent Particles and Mechanism of Thermal Stress Induced Particle Formation in HSV-2 Viral Vaccine Candidate
    Li, Lillian
    Kirkitadze, Marina
    Bhandal, Kamaljit
    Roque, Cristopher
    Yang, Eric
    Carpick, Bruce
    Rahman, Nausheen
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2017, 18 (08) : 638 - 647
  • [35] Immunization with combined HSV-2 glycoproteins B2:D2 gene DNAs:: Protection against lethal intravaginal challenges in mice
    Lee, HH
    Cha, SC
    Jang, DJ
    Lee, JK
    Choo, DW
    Kim, YS
    Uh, HS
    Kim, SY
    VIRUS GENES, 2002, 25 (02) : 179 - 188
  • [36] Immunization with combined HSV-2 glycoproteins B2:D2 gene DNAs: Protection against lethal intravaginal challenges in mice
    Hoan Lee H.
    Chul Cha S.
    June Jang D.
    Keun Lee J.
    Wan Choo D.
    Sik Kim Y.
    Sun Uh H.
    Young Kim S.
    Virus Genes, 2002, 25 (2) : 179 - 188
  • [37] Neuronal miR-138 Represses HSV-2 Lytic Infection by Regulating Viral and Host Genes with Mechanistic Differences from HSV-1
    Chen, Siyu
    Deng, Yue
    Chen, Hongjia
    Lin, Yuqi
    Yang, Xuewei
    Sun, Boqiang
    Pan, Dongli
    JOURNAL OF VIROLOGY, 2022, 96 (09)
  • [38] VIRAL FUNCTIONS AND PROGRESSIVE PHENOTYPIC CHANGES ASSOCIATED WITH TRANSFORMATION BY HERPES-SIMPLEX VIRUS TYPE-2 (HSV-2)
    MANAK, MM
    AURELIAN, L
    TSO, POP
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 50 - 50
  • [39] Antibodies against EBV, CMV, VZV, HSV-1, HSV-2, HHV-6B and borrelia Burgdorferi and viral nucleic acids in serum and CSF samples of patients with multiple sclerosis
    Kosan, T. Tetik
    Mavioglu, H.
    Sanlidag, T.
    Akcali, S.
    Ecemis, T.
    Horasan, G. Dinc
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 723 - 723
  • [40] Comparison of effects of multiple adjuvants and immunization routes on the immunogenicity and protection of HSV-2 gD subunit vaccine
    Wan, Mingming
    Yang, Xiao
    Chen, Zhijun
    Su, Weiheng
    Cai, Linjun
    Hou, Ali
    Sun, Bo
    Zhang, Yong
    Kong, Wei
    Jiang, Chunlai
    Zhou, Yan
    IMMUNOLOGY LETTERS, 2023, 260 : 11 - 21